106
Participants
Start Date
May 1, 2022
Primary Completion Date
May 27, 2024
Study Completion Date
May 27, 2024
CPL409116
CPL409116 contained in the tablet called PG242 (60 mg)
Placebo
Tablets without CPL409116 as an active substance
"Communal enterprise Hospital No. 1 of the Zhytomyr City Council, consulting and treatment department Research Center", Zhytomyr
MICS Centrum Medyczne Bydgoszcz, Bydgoszcz
"Centrum Nowoczesnych Terapii Sp. z o.o. Dobry Lekarz", Krakow
AMICARE Centrum Medyczne Sp. z o. o., Spółka Komandytowa, Lodz
Medyczne Centrum Hetmańska, Poznan
Samodzielny Publiczny Zespół Opieki Zdrowotnej w Tomaszowie Lubelskim, Tomaszów Lubelski
Wojskowy Instytut Medyczny, Warsaw
PCS Sp. z o. o., Łady
"Medical center of the limited liability company Medical center Consilium Medical", Kyiv
"Polyclinic of the center of medical services and rehabilitation JSC Company of aviation and rocket technology manufacture", Kyiv
Lead Sponsor
National Center for Research and Development, Poland
OTHER
Celon Pharma SA
INDUSTRY